LARGO, Fla., Oct. 3 /PRNewswire-FirstCall/ -- GeoPharma, Inc. a pharmaceutical company specializing in manufacturing and distributing over-the-counter, nutritional, generic drug and functional food products, announced today that Mihir Taneja, CEO of GeoPharma, Inc., will be presenting at Rodman & Renshaw’s 8th Annual Healthcare Conference in New York on Wednesday, November 8th, 2006.
The Conference will include presentations by over 300 companies, as well as experts from the medical, scientific and investment communities. The Conference will be attended by investors, venture capitalists, company executives, scientists and other industry leaders. Details regarding the conference can be obtained at www.rodmanandrenshaw.com.
About GeoPharma, Inc.
GeoPharma, Inc. is a rapidly growing pharmaceutical company specializing in the manufacturing and distribution of over-the-counter, nutritional, generic drug and functional food products. The company’s growth strategy is to capitalize on its manufacturing expertise to develop high-margin generic or novel drugs for niche markets with high barriers to entry. GeoPharma’s competitive advantage lies in its ability to circumvent or overcome the challenges in these markets. For more about GeoPharma, Inc., go to our websites at http://www.geopharmainc.com , http://www.onlineihp.com and http://www.hoodiadexl10.com .
FORWARD-LOOKING STATEMENTS
This press release may contain statements that constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including those regarding the company and its subsidiaries’ expectations, intentions, strategies and beliefs pertaining to future performance. All statements contained herein are based upon information available to the company’s management as of the date hereof, and actual results may vary based upon future events, both within and without management’s control. Important factors that could cause such differences are described in the company’s periodic filings with the Securities and Exchange Commission.
L.G. Zangani, LLC provides financial public relations services to the Company. As such, L.G. Zangani, LLC and/or its officers, agents and employees, receives remuneration for public relations and/or other services performed for the Company. This remuneration may take the form of cash, capital stock in the Company, or warrants and/or options to purchase stock in the Company.
GeoPharma, Inc.
CONTACT: Mihir Taneja of GeoPharma, Inc., +1-727-544-8866, ormihirt@onlineihp.com; or Kevin Nally of Zangani Investor Community,+1-908-788-9660, ext. 625, or office@zangani.com, for GeoPharma, Inc.
